Patient-reported financial barriers to adherence to treatment in neurology

OBJECTIVE: Many effective medical therapies are available for treating neurological diseases, but these therapies tend to be expensive and adherence is critical to their effectiveness. We used patient-reported data to examine the frequency and determinants of financial barriers to medication adherence among individuals treated for neurological disorders. PATIENTS AND METHODS: Patients completed cross-sectional surveys on iPads as part of routine outpatient care in a neurology clinic. Survey responses from a 3-month period were collected and merged with administrative sources of demographic and clinical information (eg, insurance type). We explored the association between patient characteristics and patient-reported failure to refill prescription medication due to cost in the previous 12 months, termed here as "nonadherence". RESULTS: The population studied comprised 6075 adults who were presented between July and September 2015 for outpatient neurology appointments. The mean age of participants was 56 (standard deviation: 18) years, and 1613 (54%) were females. The patients who participated in the surveys (2992, 49%) were comparable to nonparticipants with respect to gender and ethnicity but more often identified English as their preferred language (94% vs 6%, p<0.01). Among respondents, 9.8% (n=265) reported nonadherence that varied by condition. These patients were more frequently Hispanic (16.7% vs 9.8% white, p=0.01), living alone (13.9% vs 8.9% cohabitating, p<0.01), and preferred a language other than English (15.3% vs 9.4%, p=0.02). CONCLUSION: Overall, the magnitude of financial barriers to medication adherence appears to vary across neurological conditions and demographic characteristics

Automated information extraction from free-text EEG reports

In this study we have developed a supervised learning to automatically detect with high accuracy EEG reports that describe seizures and epileptiform discharges. We manually labeled 3,277 documents as describing one or more seizures vs no seizures, and as describing epileptiform discharges vs no epileptiform discharges. We then used Naïve Bayes to develop a system able to automatically classify EEG reports into these categories. Our system consisted of normalization techniques, extraction of key sentences, and automated feature selection using cross validation. As candidate features we used key words and special word patterns called elastic word sequences (EWS). Final feature selection was accomplished via sequential backward selection. We used cross validation to predict out of sample performance. Our automated feature selection procedure resulted in a classifier with 38 features for seizure detection, and 23 features for epileptiform discharge detection. The average [95% CI] area under the receiver operating curve was 99.05 [98.79, 99.32]% for detecting reports with seizures, and 96.15 [92.31, 100.00]% for detecting reports with epileptiform discharges. The methodology described herein greatly reduces the manual labor involved in identifying large cohorts of patients for retrospective neurophysiological studies of patients with epilepsy

Variability in pharmacologically-induced coma for treatment of refractory status epilepticus

Objective To characterize the amount of EEG suppression achieved in refractory status epilepticus (RSE) patients treated with pharmacologically-induced coma (PIC). Methods We analyzed EEG recordings from 35 RSE patients between 21–84 years-old who received PIC that target burst suppression and quantified the amount of EEG suppression using the burst suppression probability (BSP). Then we measured the variability of BSPs with respect to a reference level of BSP 0.8 ± 0.15. Finally, we also measured the variability of BSPs with respect to the amount of intravenous anesthetic drugs (IVADs) received by the patients. Results Patients remained in the reference BSP range for only 8% (median, interquartile range IQR [0, 29] %) of the total time under treatment. The median time with BSP below the reference range was 84% (IQR [37, 100] %). BSPs in some patients drifted significantly over time despite constant infusion rates of IVADs. Similar weight-normalized infusion rates of IVADs in different patients nearly always resulted in distinct BSPs (probability 0.93 (IQR [0.82, 1.0]). Conclusion This study quantitatively identified high variability in the amount of EEG suppression achieved in clinical practice when treating RSE patients. While some of this variability may arise from clinicians purposefully deviating from clinical practice guidelines, our results show that the high variability also arises in part from significant inter- and intra- individual pharmacokinetic/pharmacodynamic variation. Our results indicate that the delicate balance between maintaining sufficient EEG suppression in RSE patients and minimizing IVAD exposure in clinical practice is challenging to achieve. This may affect patient outcomes and confound studies seeking to determine an optimal amount of EEG suppression for treatment of RSE. Therefore, our analysis points to the need for developing an alternative paradigm, such as vigilant anesthetic management as happens in operating rooms, or closed-loop anesthesia delivery, for investigating and providing induced-coma therapy to RSE patients

O uso de centeio como cultura intercalar em videiras.

bitstream/CNPT-2010/40571/1/p-co206.pd

Hospital complications among older adults: Better processes could reduce the risk of delirium

Using observational data and variation in hospital admissions across days of the week, we examined the association between ED boarding time and development of delirium within 72 hours of admission among patients aged 65+ years admitted to an inpatient neurology ward. We exploited a natural experiment created by potentially exogenous variation in boarding time across days of the week because of competition for the neurology floor beds. Using proportional hazard models adjusting for socio-demographic and clinical characteristics in a propensity score, we examined the time to delirium onset among 858 patients: 2/3 were admitted for stroke, with the remaining admitted for another acute neurologic event. Among all patients, 81.2% had at least one delirium risk factor in addition to age. All eligible patients received delirium prevention protocols upon admission to the floor and received at least one delirium screening event. While the clinical and social-demographic characteristics of admitted patients were comparable across days of the week, patients with ED arrival on Sunday or Tuesday were more likely to have had delayed floor admission (waiting time greater than 13 hours) and delirium (adjusted HR = 1.54, 95%CI:1.37–1.75). Delayed initiation of delirium prevention protocol appeared to be associated with greater risk of delirium within the initial 72 hours of a hospital admission

Atributos de qualidade e funcionais de acessos do banco ativo de germoplasma de mangaba da Embrapa Tabuleiros Costeiros.

bitstream/item/145650/1/CT-71.pd

Proposta de metodologia para análise de produtos biológicos à base de Trichoderma.

Diversos produtos à base de Trichoderma são comercializados no Brasil. As empresas produtoras estão legalizando a sua comercialização no MAPA. Com isso, surgiu a necessidade de desenvolver métodos padronizados para avaliar a qualidade destes produtos. Assim, foi criado o Projeto Qualibio, em que um dos objetivos é desenvolver metodologia para avaliação da qualidade de produtos à base de Trichoderma. Para isso, foram desenvolvidas e validadas as metodologias para avaliar o número de conídios, a porcentagem de conídios viáveis e a UFC, determinando-se a qualidade dos produtos nas formulações pó-molhável, pó-de-esporo, grânulos dispersíveis em água e óle

Precipitação pluviométrica em áreas de Savana de Roraima: campos experimentais Monte Cristo e Água Boa.

bitstream/item/173840/1/cot01203-precipitathOoMC-moises.pd

BRS Fronteira: cultivar de arroz irrigado para os Estados do Rio Grande do Sul e São Paulo.

O lançamento desta cultivar tem como objetivo aumentar a diversidade genética e dar maior opção aos produtores gaúchos e paulistas.344, realizado pela Embrapa Arroz e Feijão em 1990.bitstream/CNPAF/25386/1/comt_124.pd